{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T05:10:18Z","timestamp":1734153018785,"version":"3.30.2"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,12]]},"DOI":"10.7759\/cureus.75617","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T04:36:37Z","timestamp":1734064597000},"source":"Crossref","is-referenced-by-count":0,"title":["Safety and Efficacy of Autologous Bone Marrow Derived Mononuclear Cell Transplant in the Management of Various Neurological Disorders"],"prefix":"10.7759","author":[{"given":"Sanjay","family":"Kala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anchal","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhagat","family":"Singh Rajput","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chayanika","family":"Kala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh K","family":"Barman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2014.01.008","article-title":"Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial","volume":"16","author":"Manc\u00edas-Guerra C","year":"2014","unstructured":"Manc\u00edas-Guerra C, Marroqu\u00edn-Escamilla AR, Gonz\u00e1lez-Llano O, et al.. Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial. Cytotherapy. 2014, 16:810-20. 10.1016\/j.jcyt.2014.01.008","journal-title":"Cytotherapy"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3727\/096368912X633798","article-title":"Administration of autologous bone marrow-derived mononuclear cells in children with incurable neurological disorders and injury is safe and improves their quality of life","volume":"21 Suppl 1","author":"Sharma A","year":"2012","unstructured":"Sharma A, Gokulchandran N, Chopra G, Kulkarni P, Lohia M, Badhe P, Jacob VC. Administration of autologous bone marrow-derived mononuclear cells in children with incurable neurological disorders and injury is safe and improves their quality of life. Cell Transplant. 2012, 21 Suppl 1:S79-90. 10.3727\/096368912X633798","journal-title":"Cell Transplant"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13081159","article-title":"Mesenchymal stromal cells perspective: new potential therapeutic for the treatment of neurological diseases","volume":"13","author":"Mukai T","year":"2021","unstructured":"Mukai T, Sei K, Nagamura-Inoue T. Mesenchymal stromal cells perspective: new potential therapeutic for the treatment of neurological diseases. Pharmaceutics. 2021, 13:10.3390\/pharmaceutics13081159","journal-title":"Pharmaceutics"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0059-14.2015","article-title":"Acute traumatic brain injury does not exacerbate amyotrophic lateral sclerosis in the sod1 (g93a) rat model","volume":"2","author":"Thomsen GM","year":"2015","unstructured":"Thomsen GM, Vit JP, Lamb A, et al.. Acute traumatic brain injury does not exacerbate amyotrophic lateral sclerosis in the sod1 (g93a) rat model. eNeuro. 2015, 2:10.1523\/ENEURO.0059-14.2015","journal-title":"eNeuro"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/623875","article-title":"Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study","volume":"2013","author":"Sharma A","year":"2013","unstructured":"Sharma A, Gokulchandran N, Sane H, et al.. Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study. Stem Cells Int. 2013, 2013:623875. 10.1155\/2013\/623875","journal-title":"Stem Cells Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/909328","article-title":"Cellular transplantation alters the disease progression in Becker's muscular dystrophy","volume":"2013","author":"Sharma A","year":"2013","unstructured":"Sharma A, Paranjape A, Sane H, Bhagawanani K, Gokulchandran N, Badhe P. Cellular transplantation alters the disease progression in Becker's muscular dystrophy. Case Rep Transplant. 2013, 2013:909328. 10.1155\/2013\/909328","journal-title":"Case Rep Transplant"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041039","article-title":"Stem cells therapy for spinal cord injury","volume":"19","author":"Gazdic M","year":"2018","unstructured":"Gazdic M, Volarevic V, Harrell CR, Fellabaum C, Jovicic N, Arsenijevic N, Stojkovic M. Stem cells therapy for spinal cord injury. Int J Mol Sci. 2018, 19:10.3390\/ijms19041039","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/glia.1067","article-title":"Transplantation of an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal cord axons","volume":"35","author":"Sasaki M","year":"2001","unstructured":"Sasaki M, Honmou O, Akiyama Y, Uede T, Hashi K, Kocsis JD. Transplantation of an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal cord axons. Glia. 2001, 35:26-34. 10.1002\/glia.1067","journal-title":"Glia"},{"key":"ref9","article-title":"Functional improvement of patients with progressive muscular dystrophy by bone marrow and umbilical cord blood mesenchymal stem cell transplantations","volume":"89","author":"Yang XF","year":"2009","unstructured":"Yang XF, Xu YF, Zhang YB, et al.. Functional improvement of patients with progressive muscular dystrophy by bone marrow and umbilical cord blood mesenchymal stem cell transplantations. Eur PMC. 2009, 89:2552-6.","journal-title":"Eur PMC"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5772\/67656","article-title":"Stem cell therapy in pediatric neurological disabilities","author":"Sharma A","year":"2017","unstructured":"Sharma A, Sane H, Gokulchandran N, et al.. Stem cell therapy in pediatric neurological disabilities. Physical Disabilities-Therapeutic Implications. Tan U (ed): Intechopen, 2017. 117:67656. 10.5772\/67656"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47967","article-title":"Evaluation of the cutting seton technique in treating high anal fistula","volume":"15","author":"Almughamsi AM","year":"2023","unstructured":"Almughamsi AM, Zaky MK, Alshanqiti AM, Alsaedi IS, Hamed HI, Alharbi TE, Elian AA. Evaluation of the cutting seton technique in treating high anal fistula. Cureus. 2023, 15:e47967. 10.7759\/cureus.47967","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3727\/096368913X672136","article-title":"A clinical study shows safety and efficacy of autologous bone marrow mononuclear cell therapy to improve quality of life in muscular dystrophy patients","volume":"22 Suppl 1","author":"Sharma A","year":"2013","unstructured":"Sharma A, Sane H, Badhe P, et al.. A clinical study shows safety and efficacy of autologous bone marrow mononuclear cell therapy to improve quality of life in muscular dystrophy patients. Cell Transplant. 2013, 22 Suppl 1:S127-38. 10.3727\/096368913X672136","journal-title":"Cell Transplant"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213476","article-title":"Stem-cell-based therapy: the celestial weapon against neurological disorders","volume":"11","author":"Zayed MA","year":"2022","unstructured":"Zayed MA, Sultan S, Alsaab HO, et al.. Stem-cell-based therapy: the celestial weapon against neurological disorders. Cells. 2022, 11:10.3390\/cells11213476","journal-title":"Cells"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00572.2018","article-title":"Impact of traumatic brain injury on amyotrophic lateral sclerosis: from bedside to bench","volume":"122","author":"Franz CK","year":"2019","unstructured":"Franz CK, Joshi D, Daley EL, et al.. Impact of traumatic brain injury on amyotrophic lateral sclerosis: from bedside to bench. J Neurophysiol. 2019, 122:1174-85. 10.1152\/jn.00572.2018","journal-title":"J Neurophysiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.20-0102","article-title":"Outcomes of bone marrow mononuclear cell transplantation combined with interventional education for autism spectrum disorder","volume":"10","author":"Nguyen Thanh L","year":"2021","unstructured":"Nguyen Thanh L, Nguyen HP, Ngo MD, et al.. Outcomes of bone marrow mononuclear cell transplantation combined with interventional education for autism spectrum disorder. Stem Cells Transl Med. 2021, 10:14-26. 10.1002\/sctm.20-0102","journal-title":"Stem Cells Transl Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2018.08.001","article-title":"Mesenchymal stromal cells as a potential therapeutic for neurological disorders","volume":"9","author":"Mukai T","year":"2018","unstructured":"Mukai T, Tojo A, Nagamura-Inoue T. Mesenchymal stromal cells as a potential therapeutic for neurological disorders. Regen Ther. 2018, 9:32-7. 10.1016\/j.reth.2018.08.001","journal-title":"Regen Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2015.2084","article-title":"Transplantation of human umbilical cord-derived mesenchymal stems cells for the treatment of Becker muscular dystrophy in affected pedigree members","volume":"35","author":"Li P","year":"2015","unstructured":"Li P, Cui K, Zhang B, et al.. Transplantation of human umbilical cord-derived mesenchymal stems cells for the treatment of Becker muscular dystrophy in affected pedigree members. Int J Mol Med. 2015, 35:1051-7. 10.3892\/ijmm.2015.2084","journal-title":"Int J Mol Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.14245\/ns.2244658.329","article-title":"Advances in neural stem cell therapy for spinal cord injury: safety, efficacy, and future perspectives","volume":"19","author":"Lee S","year":"2022","unstructured":"Lee S, Nam H, Joo KM, Lee SH. Advances in neural stem cell therapy for spinal cord injury: safety, efficacy, and future perspectives. Neurospine. 2022, 19:946-60. 10.14245\/ns.2244658.329","journal-title":"Neurospine"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705757","article-title":"Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury","volume":"40","author":"Parr AM","year":"2007","unstructured":"Parr AM, Tator CH, Keating A. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant. 2007, 40:609-19. 10.1038\/sj.bmt.1705757","journal-title":"Bone Marrow Transplant"},{"key":"ref20","article-title":"Role of stem cell therapy in treatment of muscular dystrophy","author":"Sharma A","year":"2016","unstructured":"Sharma A, Badhe P, Sane H, Gokulchandran N, Paranjape A. Role of stem cell therapy in treatment of muscular dystrophy. Muscular Dystrophy. SM Grouups, India; 2016. 1-22."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2003.11.023","article-title":"Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells","volume":"9","author":"Skuk D","year":"2004","unstructured":"Skuk D, Roy B, Goulet M, et al.. Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol Ther. 2004, 9:475-82. 10.1016\/j.ymthe.2003.11.023","journal-title":"Mol Ther"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/biology11010147","article-title":"Stem cell transplantation therapy and neurological disorders: current status and future perspectives","volume":"11","author":"Rahman MM","year":"2022","unstructured":"Rahman MM, Islam MR, Islam MT, et al.. Stem cell transplantation therapy and neurological disorders: current status and future perspectives. Biology (Basel). 2022, 11:10.3390\/biology11010147","journal-title":"Biology (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2021.0094","article-title":"Autophagy and apoptosis in acute brain injuries: from mechanism to treatment","volume":"38","author":"He C","year":"2023","unstructured":"He C, Xu Y, Sun J, Li L, Zhang JH, Wang Y. Autophagy and apoptosis in acute brain injuries: from mechanism to treatment. Antioxid Redox Signal. 2023, 38:234-57. 10.1089\/ars.2021.0094","journal-title":"Antioxid Redox Signal"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/978-4-431-55678-7_8","article-title":"Stem cell-based therapy for duchenne muscular dystrophy","author":"Miyagoe-Suzuki Y","year":"2016","unstructured":"Miyagoe-Suzuki Y, Takeda SI. Stem cell-based therapy for duchenne muscular dystrophy. Translational Research in Muscular Dystrophy. Takeda S, Miyagoe-Suzuki Y, Mori-Yoshimura M (ed): Springer, Tokyo; 2016. 123-35. 10.1007\/978-4-431-55678-7_8"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-018-0992-x","article-title":"The effects of bone marrow mononuclear cell transplantation on the quality of life of children with cerebral palsy","volume":"16","author":"Nguyen TL","year":"2018","unstructured":"Nguyen TL, Nguyen HP, Nguyen TK. The effects of bone marrow mononuclear cell transplantation on the quality of life of children with cerebral palsy. Health Qual Life Outcomes. 2018, 16:164. 10.1186\/s12955-018-0992-x","journal-title":"Health Qual Life Outcomes"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/323999-safety-and-efficacy-of-autologous-bone-marrow-derived-mononuclear-cell-transplant-in-the-management-of-various-neurological-disorders","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T04:36:39Z","timestamp":1734064599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/323999-safety-and-efficacy-of-autologous-bone-marrow-derived-mononuclear-cell-transplant-in-the-management-of-various-neurological-disorders"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.75617","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,12]]}}}